Malonic acid suppresses lipopolysaccharide-induced BV2 microglia cell activation by inhibiting the p38 MAPK/NF-κB...

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Microglial activation triggers neuroinflammation, contributing to neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Regulating neuroinflammation is crucial for preventing neurodegenerative disease progression.
• Malonic acid exhibits various biological activities, but its effects on microglia remain largely unexplored.

Purpose of the Study:

• To investigate the anti-inflammatory effects of malonic acid on microglia.
• To elucidate the molecular mechanisms underlying malonic acid's action in inflammatory conditions.

Main Methods:

• Utilized BV2 microglia cells stimulated with lipopolysaccharide (LPS) to model neuroinflammation.
• Assessed the impact of malonic acid on pro-inflammatory mediator production, including nitric oxide and reactive oxygen species.
• Analyzed the gene expression of pro-inflammatory cytokines like IL-6.
• Examined the protein expression and cellular localization of key signaling pathway components, including NF-κB, IκB-α, and p38 MAPK.

Main Results:

• Malonic acid significantly decreased LPS-induced pro-inflammatory responses in microglia.
• Reduced production of nitric oxide and reactive oxygen species was observed with malonic acid treatment.
• Suppressed gene expression of the pro-inflammatory cytokine IL-6.
• Decreased nuclear translocation of NF-κB and reduced expression of phosphorylated IκB-α.
• Regulated the expression of phosphorylated p38, a critical mediator in inflammatory signaling pathways.

Conclusions:

• Malonic acid demonstrates significant anti-inflammatory properties in microglia.
• The compound modulates the p38 MAPK/NF-κB signaling pathway, a key regulator of inflammation.
• Malonic acid presents potential as a therapeutic agent for managing neuroinflammatory diseases.